コクシジオイデス症の世界市場レポート 2025年

コクシジオイデス症市場規模は、今後数年間で力強い成長が見込まれます。2029年には12億9,000万米ドルに成長し、CAGRは5.4%となります。予測期間中の成長は、遠隔医療の普及、抗真菌剤耐性に関する研究の増加、ワクチン開発への資金提供の増加、高リスク地域への人口移動の増加、抗真菌剤治療の利用可能性の拡大などの要因によるものと考えられます。この期間に予想される主な動向としては、技術革新、抗真菌薬需要の急増、ワクチン開発の主な発展、遠隔医療の継続的成長、国境を越えた協力体制の強化などが挙げられます。

真菌胞子への曝露の増加がコクシジオイデス症市場の成長を牽引すると予想されます。真菌の胞子は、空気、水、または表面を通して拡散することができる真菌によって生産される小さな繁殖単位であり、真菌が新しい環境で成長し、繁殖することを可能にします。森林伐採や気象パターンの変化などの要因により、これらの芽胞にさらされる機会が増加しており、土壌が破壊され芽胞の放出が促進されています。特にコクシジオイデス菌が繁殖する乾燥地域では、コクシジオイデス症のような感染症のリスクが高くなります。コクシジオイデス症の治療は、症状を緩和し、合併症を予防し、真菌の増殖を抑えることで、真菌の芽胞にさらされた人々を助け、最終的には回復と生活の質を向上させる。例えば、2024年9月、国際感染症学会は、侵襲性真菌感染症は年間約650万人が罹患し、約380万人が死亡しており、これらの感染症に直接関連する死亡者は約250万人であると報告しています。従って、真菌胞子への曝露の増加がコクシジオイデス症市場の成長を促進しています。

ヘルスケア施設の成長がコクシジオイデス症市場を押し上げると予測されています。ヘルスケア施設とは、効果的なヘルスケアサービスを提供するために必要不可欠なインフラ、システム、リソースを指します。遠隔医療、ロボット手術、AIによる診断などのイノベーションには、患者の転帰と業務効率を高めるために、アップグレードされた施設、専門機器、改善された医療提供システムが必要であるため、ヘルスケアインフラの拡大は医療技術の進歩によって推進されます。これらの施設は、早期診断、抗真菌治療、患者教育、症状管理や合併症予防のための継続的なケアを提供することで、コクシジオイデス症の治療をサポートしています。例えば、米国病院協会の報告によると、米国の病院数は2022年の6,093から2024年には6,120に増加します。その結果、ヘルスケアインフラの成長がコクシジオイデス症市場の拡大を後押ししています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のコクシジオイデス症 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のコクシジオイデス症市場：成長率分析
• 世界のコクシジオイデス症市場の実績：規模と成長, 2019-2024
• 世界のコクシジオイデス症市場の予測：規模と成長, 2024-2029, 2034F
• 世界のコクシジオイデス症総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のコクシジオイデス症市場：治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• フルコナゾール
• イトラコナゾール
• ボリコナゾール
• ポサコナゾール
• その他の治療法
• 世界のコクシジオイデス症市場：感染部位別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 肌
• 肺
• 肝臓
• 骨
• 心臓
• 脳
• 脳と脊髄を囲む膜
• その他の感染部位
• 世界のコクシジオイデス症市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ヒト
• ウシ
• ヒツジとヤギ
• ラクダ
• その他のエンドユーザー
• 世界のコクシジオイデス症市場：タイプ別サブセグメンテーション、フルコナゾール、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口フルコナゾール
• 静脈内フルコナゾール
• 世界のコクシジオイデス症市場：タイプ別サブセグメンテーション、イトラコナゾール、実績と予測, 2019-2024, 2024-2029F, 2034F
• イトラコナゾールカプセル
• 経口液イトラコナゾール
• 世界のコクシジオイデス症市場：タイプ別サブセグメンテーション、ボリコナゾール、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口ボリコナゾール
• 静脈内ボリコナゾール
• 世界のコクシジオイデス症市場：タイプ別サブセグメンテーション、ポサコナゾール、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口懸濁液ポサコナゾール
• 遅延放出錠ポサコナゾール
• 静脈内ポサコナゾール
• 世界のコクシジオイデス症市場：タイプ別サブセグメンテーション、その他の治療、実績と予測, 2019-2024, 2024-2029F, 2034F
• 併用療法
• 補助療法

第7章 地域別・国別分析

• 世界のコクシジオイデス症市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のコクシジオイデス症市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• コクシジオイデス症市場：競合情勢
• コクシジオイデス症市場：企業プロファイル
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Fresenius Kabi Overview, Products and Services, Strategy and Financial Analysis
  • Dr. Reddy's Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Horster Life Science Overview, Products and Services, Strategy and Financial Analysis
  • Mankind Pharma Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Atom Pharma
• Ravoos Laboratories
• Casca Remedies
• Hema Pharmaceuticals
• Globela Pharma
• Spansules Pharmatech
• Sanes Pharmaceuticals
• CDH Chemicals
• Sainor Laboratories
• Maithili Life Sciences
• Stratechem（I）Pvt. Ltd.
• Shantam Pharma
• Cerata Pharmaceuticals
• Aden Healthcare
• Kabir Lifesciences

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• コクシジオイデス症市場2029：新たな機会を提供する国
• コクシジオイデス症市場2029：新たな機会を提供するセグメント
• コクシジオイデス症市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Valley fever, also known as coccidioidomycosis, is a fungal infection that mainly affects the lungs, causing symptoms such as cough, fever, fatigue, and chest pain. In some cases, it can lead to severe complications. The infection is caused by inhaling airborne spores from the coccidioides fungi, which are commonly found in dry, dusty soil and become airborne when the soil is disturbed.

The primary treatment options for valley fever include fluconazole, itraconazole, voriconazole, posaconazole, and others. Fluconazole is an antifungal medication that works by inhibiting the growth of fungi to treat fungal infections. The infection can affect various sites, including the skin, lungs, liver, bones, heart, brain, and the membranes surrounding the brain and spinal cord. These treatments are used for a range of end-users, including humans, cattle, sheep, goats, camels, and others.

The valley fever market research report is one of a series of new reports from The Business Research Company that provides valley fever market statistics, including valley fever industry global market size, regional shares, competitors with a valley fever market share, detailed valley fever market segments, market trends and opportunities, and any further data you may need to thrive in the valley fever industry. This valley fever market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The valley fever market size has grown strongly in recent years. It will grow from $0.99 billion in 2024 to $1.05 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth during the historic period can be attributed to factors such as the increasing effects of climate change driving the spread of fungal infections, rising research funding for Valley Fever treatments, greater investments in healthcare, growing demand for specialized diagnostic laboratories, and a rising incidence of Valley Fever in non-endemic regions.

The valley fever market size is expected to see strong growth in the next few years. It will grow to $1.29 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The projected growth during the forecast period can be attributed to factors such as the increasing adoption of telemedicine, a rise in research on antifungal resistance, growing funding for vaccine development, higher population movement across high-risk areas, and the expanding availability of antifungal treatments. Key trends expected in this period include technological innovations, a surge in demand for antifungal drugs, advancements in vaccine development, the continued growth of telemedicine, and enhanced cross-border collaboration.

The increasing exposure to fungus spores is expected to drive the growth of the valley fever market. Fungus spores are tiny reproductive units produced by fungi that can spread through air, water, or surfaces, allowing the fungus to grow and reproduce in new environments. Exposure to these spores has been rising due to factors such as deforestation and shifting weather patterns, which disrupt the soil and promote the release of spores. This leads to a higher risk of infections such as valley fever, particularly in arid regions where the coccidioides fungus thrives. Valley fever treatments help those exposed to fungal spores by alleviating symptoms, preventing complications, and controlling fungal growth, ultimately improving recovery and quality of life. For example, in September 2024, the International Society for Infectious Diseases reported that invasive fungal infections affect about 6.5 million people annually, causing nearly 3.8 million deaths, with approximately 2.5 million deaths directly related to these infections. Therefore, the rising exposure to fungus spores is fueling the growth of the valley fever market.

The growth of healthcare facilities is anticipated to boost the valley fever market. Healthcare facilities refer to the essential infrastructure, systems, and resources required to provide effective healthcare services. The expansion of healthcare infrastructure is driven by advances in medical technology, as innovations such as telemedicine, robotic surgery, and AI-driven diagnostics require upgraded facilities, specialized equipment, and improved healthcare delivery systems to enhance patient outcomes and operational efficiency. These facilities support the treatment of valley fever by offering early diagnosis, antifungal treatments, patient education, and ongoing care to manage symptoms and prevent complications. For instance, the American Hospital Association reported that in 2024, there were 6,120 hospitals in the United States, up from 6,093 in 2022. As a result, the growth in healthcare infrastructure is driving the expansion of the valley fever market.

Companies in the valley fever market are focusing on developing innovative vaccines to combat the growing threat of fungal infections. These vaccines aim to protect individuals by using advanced scientific methods and manufacturing techniques, which enhance public health and safety. For instance, in August 2024, Anivive Lifesciences Inc., a U.S.-based pet pharmaceutical company, received a contract worth up to $33 million from the National Institute of Allergy and Infectious Diseases (NIAID) to develop a human vaccine for valley fever. The funding will support further manufacturing, formulation, extensive safety testing, and a Phase 1 clinical trial, with the goal of delivering the first vaccine to prevent this serious systemic fungal infection.

Major players in the valley fever market are Merck & Co. Inc., Fresenius Kabi, Dr. Reddy's Laboratories, Horster Life Science, Mankind Pharma, Atom Pharma, Ravoos Laboratories, Casca Remedies, Hema Pharmaceuticals, Globela Pharma, Spansules Pharmatech, Sanes Pharmaceuticals, CDH Chemicals, Sainor Laboratories, Maithili Life Sciences, Stratechem (I) Pvt. Ltd., Shantam Pharma, Cerata Pharmaceuticals, Aden Healthcare, Kabir Lifesciences.

North America was the largest region in the valley fever market in 2024. The regions covered in valley fever report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the Valley Fever market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The valley fever market consists of sales of antifungal medications and steroids. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Valley Fever Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on valley fever market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for valley fever ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The valley fever market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Types Of Treatment: Fluconazole; Itraconazole; Voriconazole; Posaconazole; Others Types Of Treatment
• 2) By Site Of Infection: Skin; Lungs; Liver; Bones; Heart; Brain; Membranes That Surround The Brain And Spinal Cord; Other Sites Of Infection
• 3) By End-Users: Human; Cattle; Sheep And Goats; Camel; Other End-Users
• Sub Segments:
• 1) By Fluconazole Type: Oral Fluconazole; Intravenous Fluconazole
• 2) By Itraconazole Type: Capsule Itraconazole; Oral Solution Itraconazole
• 3) By Voriconazole Type: Oral Voriconazole; Intravenous Voriconazole
• 4) By Posaconazole Type: Oral Suspension Posaconazole; Delayed-Release Tablets Posaconazole; Intravenous Posaconazole
• 5) By Other Treatment Types: Combination Therapy; Adjunctive Therapy
• Companies Mentioned: Merck & Co. Inc.; Fresenius Kabi; Dr. Reddy's Laboratories; Horster Life Science; Mankind Pharma
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Valley Fever Market Characteristics

3. Valley Fever Market Trends And Strategies

4. Valley Fever Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Valley Fever Growth Analysis And Strategic Analysis Framework

• 5.1. Global Valley Fever PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Valley Fever Market Growth Rate Analysis
• 5.4. Global Valley Fever Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Valley Fever Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Valley Fever Total Addressable Market (TAM)

6. Valley Fever Market Segmentation

• 6.1. Global Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fluconazole
• Itraconazole
• Voriconazole
• Posaconazole
• Others Types Of Treatment
• 6.2. Global Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Skin
• Lungs
• Liver
• Bones
• Heart
• Brain
• Membranes That Surround The Brain And Spinal Cord
• Other Sites Of Infection
• 6.3. Global Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Human
• Cattle
• Sheep And Goats
• Camel
• Other End-Users
• 6.4. Global Valley Fever Market, Sub-Segmentation Of Fluconazole, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Fluconazole
• Intravenous Fluconazole
• 6.5. Global Valley Fever Market, Sub-Segmentation Of Itraconazole, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Capsule Itraconazole
• Oral Solution Itraconazole
• 6.6. Global Valley Fever Market, Sub-Segmentation Of Voriconazole, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Voriconazole
• Intravenous Voriconazole
• 6.7. Global Valley Fever Market, Sub-Segmentation Of Posaconazole, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Suspension Posaconazole
• Delayed-Release Tablets Posaconazole
• Intravenous Posaconazole
• 6.8. Global Valley Fever Market, Sub-Segmentation Of Others Types Of Treatment, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Combination Therapy
• Adjunctive Therapy

7. Valley Fever Market Regional And Country Analysis

• 7.1. Global Valley Fever Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Valley Fever Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Valley Fever Market

• 8.1. Asia-Pacific Valley Fever Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Valley Fever Market

• 9.1. China Valley Fever Market Overview
• 9.2. China Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Valley Fever Market

• 10.1. India Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Valley Fever Market

• 11.1. Japan Valley Fever Market Overview
• 11.2. Japan Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Valley Fever Market

• 12.1. Australia Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Valley Fever Market

• 13.1. Indonesia Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Valley Fever Market

• 14.1. South Korea Valley Fever Market Overview
• 14.2. South Korea Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Valley Fever Market

• 15.1. Western Europe Valley Fever Market Overview
• 15.2. Western Europe Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Valley Fever Market

• 16.1. UK Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Valley Fever Market

• 17.1. Germany Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Valley Fever Market

• 18.1. France Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Valley Fever Market

• 19.1. Italy Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Valley Fever Market

• 20.1. Spain Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Valley Fever Market

• 21.1. Eastern Europe Valley Fever Market Overview
• 21.2. Eastern Europe Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Valley Fever Market

• 22.1. Russia Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Valley Fever Market

• 23.1. North America Valley Fever Market Overview
• 23.2. North America Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Valley Fever Market

• 24.1. USA Valley Fever Market Overview
• 24.2. USA Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Valley Fever Market

• 25.1. Canada Valley Fever Market Overview
• 25.2. Canada Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Valley Fever Market

• 26.1. South America Valley Fever Market Overview
• 26.2. South America Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Valley Fever Market

• 27.1. Brazil Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Valley Fever Market

• 28.1. Middle East Valley Fever Market Overview
• 28.2. Middle East Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Valley Fever Market

• 29.1. Africa Valley Fever Market Overview
• 29.2. Africa Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Valley Fever Market Competitive Landscape And Company Profiles

• 30.1. Valley Fever Market Competitive Landscape
• 30.2. Valley Fever Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Fresenius Kabi Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Dr. Reddy's Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Horster Life Science Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Mankind Pharma Overview, Products and Services, Strategy and Financial Analysis

31. Valley Fever Market Other Major And Innovative Companies

• 31.1. Atom Pharma
• 31.2. Ravoos Laboratories
• 31.3. Casca Remedies
• 31.4. Hema Pharmaceuticals
• 31.5. Globela Pharma
• 31.6. Spansules Pharmatech
• 31.7. Sanes Pharmaceuticals
• 31.8. CDH Chemicals
• 31.9. Sainor Laboratories
• 31.10. Maithili Life Sciences
• 31.11. Stratechem (I) Pvt. Ltd.
• 31.12. Shantam Pharma
• 31.13. Cerata Pharmaceuticals
• 31.14. Aden Healthcare
• 31.15. Kabir Lifesciences

32. Global Valley Fever Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Valley Fever Market

34. Recent Developments In The Valley Fever Market

35. Valley Fever Market High Potential Countries, Segments and Strategies

• 35.1 Valley Fever Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Valley Fever Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Valley Fever Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer